Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-25-100720

Options or other derivatives

  • Director acquired 3,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klompas Neil A · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-17 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +3,500 3,500 D
Loading xslF345X05/ownership.xml…